Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02921919
Title Open-Label Extension and Safety Study of Talazoparib
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Medivation, Inc.
Indications

Advanced Solid Tumor

hematologic cancer

Therapies

Talazoparib

Age Groups: child | senior | adult
Covered Countries USA | FRA | DEU | CAN


No variant requirements are available.